Akoya Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference
05 January 2022 - 12:05AM
Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial
Biology Company®, today announced that it will be virtually
participating in the 40th Annual J.P. Morgan Healthcare Conference.
Brian McKelligon, CEO, is scheduled to present on Thursday,
January 13th, 2022 at 9:00 a.m. ET.
A live and archived webcast of the event will be available on
the “Investors” section of the Akoya website at
https://investors.akoyabio.com/.
About Akoya BiosciencesAs The Spatial Biology
Company®, Akoya Biosciences’ mission is to bring context to the
world of biology and human health through the power of spatial
phenotyping. The company offers comprehensive single-cell imaging
solutions that allow researchers to phenotype cells with spatial
context and visualize how they organize and interact to influence
disease progression and treatment response. Akoya offers two
distinct solutions, the CODEX® and Phenoptics™ platforms, to serve
the diverse needs of researchers across discovery, translational
and clinical research.
Investor Contact:Priyam ShahAkoya
Biosciencesinvestors@akoyabio.com
Media Contact:Michelle LinnBioscribe,
Inc.774-696-3803michelle@bioscribe.com
Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
From Apr 2023 to Apr 2024
